Interrupted time-series analyses of routine vaccination program for elderly pneumonia patients in Japan; an ecological study using aggregated nationwide inpatient data

References

• Miyashita N, Yamauchi Y. Bacterial pneumonia in elderly Japanese populations. Jpn Clin Med. 2018;9:1179670717751433. doi:10.1177/1179670717751433.
   Web of Science ®Google Scholar
• Morimoto K, Suzuki M, Ishifuji T, Yaegashi M, Asoh N, Hamashige N, Abe M, Aoshima M, Ariyoshi K. The burden and etiology of community-onset pneumonia in the aging Japanese population: a multicenter prospective study. PLoS ONE. 2015;10:e0122247. doi:10.1371/journal.pone.0122247.
   PubMed Web of Science ®Google Scholar
• Konomura K, Nagai H, Akazawa M. Economic burden of community-acquired pneumonia among elderly patients: a Japanese perspective. Pneumonia (Nathan). 2017;9:19. doi:10.1186/s41479-017-0042-1.
   PubMedGoogle Scholar
• Ishiguro T, Takayanagi N, Yamaguchi S, Yamakawa H, Nakamoto K, Takaku Y, Miyahara Y, Kagiyama N, Kurashima K, Yanagisawa T, et al. Etiology and factors contributing to the severity and mortality of community-acquired pneumonia. Int Med. 2013;52:317–24. doi:10.2169/internalmedicine.52.8830.
   PubMed Web of Science ®Google Scholar
• Maruyama T, Niederman MS, Kobayashi T, Kobayashi H, Takagi T, D’Alessandro-Gabazza CN, Fujimoto H, Gil Bernabe P, Hirohata S, Nakayama S, et al. A prospective comparison of nursing home-acquired pneumonia with hospital-acquired pneumonia in non-intubated elderly. Respir Med. 2008;102:1287–95. doi:10.1016/j.rmed.2008.03.027.
   PubMed Web of Science ®Google Scholar
• Ubukata K, Chiba N, Hanada S, Morozumi M, Wajima T, Shouji M, Iwata S. Invasive pneumococcal diseases surveillance study group. Serotype changes and drug resistance in invasive pneumococcal diseases in adults after vaccinations in children, Japan, 2010-2013. Emerging Infect Dis. 2015;21:1956–65. doi:10.3201/eid2111.142029.
   PubMed Web of Science ®Google Scholar
• Oishi K, Yoshimine H, Watanabe H, Watanabe K, Tanimura S, Kawakami K, Iwagaki A, Nagai H, Goto H, Kudoh S, et al. Drug-resistant genes and serotypes of pneumococcal strains of community-acquired pneumonia among adults in Japan. Respirology. 2006;11:429–36. doi:10.1111/j.1440-1843.2006.00867.x.
   PubMed Web of Science ®Google Scholar
• Fukusumi M, Chang B, Tanabe Y, Oshima K, Maruyama T, Watanabe H, Kuronuma K, Kasahara K, Takeda H, Nishi J, et al. Invasive pneumococcal disease among adults in Japan, April 2013 to March 2015: disease characteristics and serotype distribution. BMC Infect Dis. 2017;17:2. doi:10.1186/s12879-016-2113-y.
   PubMed Web of Science ®Google Scholar
• Shapiro ED, Berg AT, Austrian R, Schroeder D, Parcells V, Margolis A, Adair RK, Clemens JD. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med. 1991;325:1453–60. doi:10.1056/NEJM199111213252101.
   PubMed Web of Science ®Google Scholar
• Jackson LA, Neuzil KM, Yu O, Benson P, Barlow WE, Adams AL, Hanson CA, Mahoney LD, Shay DK, Thompson WW. Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med. 2003;348:1747–55. doi:10.1056/NEJMoa022678.
   PubMed Web of Science ®Google Scholar
• Ogilvie I, El Khoury A, Cui Y, Dasbach E, Grabenstein JD, Goetghebeur M. Cost-effectiveness of pneumococcal polysaccharide vaccination in adults: A systematic review of conclusions and assumptions. Vaccine. 2009;27:4891–904. doi:10.1016/j.vaccine.2009.05.061.
   PubMed Web of Science ®Google Scholar
• Moberley S, Holden J, Tatham DP, Andrews RM. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev. 2013;1:CD000422. doi:10.1002/14651858.CD000422.pub3.
   PubMed Web of Science ®Google Scholar
• Fisman DN, Abrutyn E, Spaude KA, Kirchner AKC, Daley J. Prior pneumococcal vaccination is associated with reduced death, complications, and length of stay among hospitalized adults with community-acquired pneumonia. Clin Infect Dis. 2006;42:1093–101. doi:10.1086/501354.
   PubMed Web of Science ®Google Scholar
• Suzuki M, Dhoubhadel BG, Ishifuji T, Yasunami M, Yaegashi M, Asoh N, Ishida M, Hamaguchi S, Aoshima M, Ariyoshi K, et al. Serotype-specific effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia in adults aged 65 years or older: a multicentre, prospective, test-negative design study. Lancet Infect Dis. 2017;17:313–21. doi:10.1016/S1473-3099(17)30049-X.
   PubMed Web of Science ®Google Scholar
• Maruyama T, Taguchi O, Niederman MS, Morser J, Kobayashi H, Kobayashi T, D’Alessandro-Gabazza C, Nakayama S, Nishikubo K, Noguchi T, et al. Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo controlled trial. BMJ. 2010;340:c1004. doi:10.1136/bmj.c1004.
   PubMed Web of Science ®Google Scholar
• Kawakami K, Ohkusa Y, Kuroki R, Tanaka T, Koyama K, Harada Y, Iwanaga K, Yamaryo T, Oishi K. Effectiveness of pneumococcal polysaccharide vaccine against pneumonia and cost analysis for the elderly who receive seasonal influenza vaccine in Japan. Vaccine. 2010;28:7063–69. doi:10.1016/j.vaccine.2010.08.010.
   PubMed Web of Science ®Google Scholar
• Diao W-Q, Shen N, Yu P-X, Liu B-B, He B. Efficacy of 23-valent pneumococcal polysaccharide vaccine in preventing community-acquired pneumonia among immunocompetent adults: a systematic review and meta-analysis of randomized trials. Vaccine. 2016;34:1496–503. doi:10.1016/j.vaccine.2016.02.023.
   PubMed Web of Science ®Google Scholar
• Huss A, Scott P, Stuck AE, Trotter C, Egger M. Efficacy of pneumococcal vaccination in adults: a meta-analysis. CMAJ. 2009;180:48–58. doi:10.1503/cmaj.1090018.
   PubMed Web of Science ®Google Scholar
• Gessner BD, Theilacker C, Jodar L. Rethinking results from the Japanese 23-valent pneumococcal polysaccharide vaccine randomized clinical trial. Vaccine. 2019;37:4853–57. doi:10.1016/j.vaccine.2019.07.040.
   PubMed Web of Science ®Google Scholar
• Jung S-M, Lee H, Nishiura H. The impact of pneumococcal vaccination on pneumonia mortality among the elderly in Japan: a difference-in-difference study. PeerJ. 2018;6:e6085. doi:10.7717/peerj.6085.
   PubMed Web of Science ®Google Scholar
• Ministry of International Affairs and Communications. Statistics Bureau of Japan, population estimates. [accessed 2019 Dec 7]. https://www.stat.go.jp/english/index.html.
   Google Scholar
• Fry AM, Shay DK, Holman RC, Curns AT, Anderson LJ. Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988-2002. JAMA. 2005;294:2712–19. doi:10.1001/jama.294.21.2712.
   PubMed Web of Science ®Google Scholar
• Tokgoz Akyil F, Yalcinsoy M, Hazar A, Cilli A, Celenk B, Kilic O, Sayiner A, Kokturk N, Sakar Coskun A, Filiz A, et al. Prognosis of hospitalized patients with community-acquired pneumonia. Pulmonology. 2018;24:164–69. doi:10.1016/j.rppnen.2017.07.010.
   Web of Science ®Google Scholar
• Bernal JL, Cummins S, Gasparrini A. Interrupted time series regression for the evaluation of public health interventions: a tutorial. Int J Epidemiol. 2017;46:348–55. doi:10.1093/ije/dyw098.
   PubMed Web of Science ®Google Scholar
• National Institute of Infectious Diseases. [accessed 2019 Dec 7].https://www.niid.go.jp/niid/images/idsc/disease/influ/fludoco1415-2.pdf.
   Google Scholar
• National Institute of Infectious Diseases. [accessed 2019 Dec 7]. https://www.niid.go.jp/niid/images/idsc/disease/influ/fludoco1516.pdf.
   Google Scholar
• Shrestha S, Foxman B, Berus J, van Panhuis WG, Steiner C, Viboud C, Rohani P. The role of influenza in the epidemiology of pneumonia. Sci Rep. 2015;5:15314. doi:10.1038/srep15314.
   PubMed Web of Science ®Google Scholar
• The Japanese Respiratory Society. [accessed 2019 Dec 7]. http://www.jrs.or.jp/uploads/uploads/files/photos/1096.pdf.
   Google Scholar
• Yamana H, Moriwaki M, Horiguchi H, Kodan M, Fushimi K, Yasunaga H. Validity of diagnoses, procedures, and laboratory data in Japanese administrative data. J Epidemiol. 2017;27:476–82. doi:10.1016/j.je.2016.09.009.
   PubMed Web of Science ®Google Scholar
• Grijalva CG, Nuorti JP, Arbogast PG, Martin SW, Edwards KM, Griffin MR. Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis. Lancet. 2007;369:1179–86. doi:10.1016/S0140-6736(07)60564-9.
   PubMed Web of Science ®Google Scholar
• Feikin DR, Kagucia EW, Loo JD, Link-Gelles R, Puhan MA, Cherian T, Levine OS, Whitney CG, O’Brien KL, Moore MR, the Serotype Replacement Study Group. Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites. PLoS Med. 2013;10:e1001517. doi:10.1371/journal.pmed.1001517.
   PubMed Web of Science ®Google Scholar
• Simonsen L, Taylor RJ, Young-Xu Y, Haber M, May L, Klugman KP. Impact of pneumococcal conjugate vaccination of infants on pneumonia and influenza hospitalization and mortality in all age groups in the United States. MBio. 2011;2:e00309–10. doi:10.1128/mBio.00309-10.
   PubMed Web of Science ®Google Scholar
• Tsaban G, Ben-Shimol S. Indirect (herd) protection, following pneumococcal conjugated vaccines introduction: a systematic review of the literature. Vaccine. 2017;35:2882–91. doi:10.1016/j.vaccine.2017.04.032.
   PubMed Web of Science ®Google Scholar
• Suga S, Chang B, Asada K, Akeda H, Nishi J, Okada K, Wakiguchi H, Maeda A, Oda M, Ishiwada N, et al. Nationwide population-based surveillance of invasive pneumococcal disease in Japanese children: effects of the seven-valent pneumococcal conjugate vaccine. Vaccine. 2015;33:6054–60. doi:10.1016/j.vaccine.2015.07.069.
   PubMed Web of Science ®Google Scholar
• Alicino C, Paganino C, Orsi A, Astengo M, Trucchi C, Icardi G, Ansaldi F. The impact of 10-valent and 13-valent pneumococcal conjugate vaccines on hospitalization for pneumonia in children: A systematic review and meta-analysis. Vaccine. 2017;35:5776–85. doi:10.1016/j.vaccine.2017.09.005.
   PubMed Web of Science ®Google Scholar
• Ubukata K, Takata M, Morozumi M, Chiba N, Wajima T, Hanada S, Shouji M, Sakuma M, Iwata S, the Invasive Pneumococcal Diseases Surveillance Study Group. Effects of pneumococcal conjugate vaccine on genotypic penicillin resistance and serotype changes, Japan, 2010–2017. Emerging Infect Dis. 2018;24:2010–20. doi:10.3201/eid2411.180326.
   PubMed Web of Science ®Google Scholar
• Number of routine immunizations. Ministry of Health. Tokyo (Japan): Labour and Welfare. [accessed 2014 Oct 21].
   Google Scholar
• Shrestha S, Foxman B, Weinberger DM, Steiner C, Viboud C, Rohani P. Identifying the interaction between influenza and pneumococcal pneumonia using incidence data. Sci Transl Med. 2013;5:191ra84. doi:10.1126/scitranslmed.3005982.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) - United States, May-August 2009. MMWR Morb Mortal Wkly Rep. 2009;58:1071–74.
   PubMedGoogle Scholar
• Cillóniz C, Ewig S, Menéndez R, Ferrer M, Polverino E, Reyes S, Gabarrús A, Marcos MA, Cordoba J, Mensa J, et al. Bacterial co-infection with H1N1 infection in patients admitted with community acquired pneumonia. J Infect. 2012;65:223–30. doi:10.1016/j.jinf.2012.04.009.
   PubMed Web of Science ®Google Scholar
• OECD. Vaccinations, in Health at a Glance 2019: OECD Indicators. Paris: OECD Publishing; 2019.
   Google Scholar
• Shafagati N, Williams J. Human metapneumovirus - what we know now. Version 1. F1000Res. 2018;7:135. doi:10.12688/f1000research.12625.1.
   PubMedGoogle Scholar